Avoro Capital Advisors LLC Praxis Precision Medicines, Inc. Transaction History

Avoro Capital Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.75 - $11.34 $3.76 Million - $24.4 Million	-2,150,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$10.21 - $20.29 $3.78 Million - $7.51 Million	370,000 Added 20.79%	2,150,000 $22 Million
Q4 2021 Feb 14, 2022	BUY	$16.76 - $22.99 $3.02 Million - $4.14 Million	180,000 Added 11.25%	1,780,000 $35.1 Million
Q2 2021 Aug 16, 2021	BUY	$18.28 - $33.05 $64,071 - $115,840	3,505 Added 0.22%	1,600,000 $29.2 Million
Q1 2021 May 17, 2021	BUY	$29.34 - $60.2 $1.5 Million - $3.07 Million	51,000 Added 3.3%	1,596,495 $47.4 Million
Q4 2020 Feb 16, 2021	BUY	$27.25 - $55.82 $42.1 Million - $86.3 Million	1,545,495 New	1,545,495 $68.7 Million

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.26B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Avoro Capital Advisors LLC with notifications on news.